|
1
|
Calaminus G, Baust K, Berger C, Byrne J,
Binder H, Casagranda L, Grabow D, Grootenhuis M, Kaatsch P, Kaiser
M, et al: Health-related quality of life in european childhood
cancer survivors: Protocol for a study within PanCareLIFE. JMIR Res
Protoc. 10:e218512021. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Armstrong GT, Liu Q, Yasui Y, Neglia JP,
Leisenring W, Robison LL and Mertens AC: Late mortality among
5-year survivors of childhood cancer: A summary from the childhood
cancer survivor study. J Clin Oncol. 27:2328–2338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhuller KS, Zhang Y, Li D, Sehn LH,
Goddard K, Mcbride ML and Rogers PC: Late mortality, secondary
malignancy and hospitalisation in teenage and young adult survivors
of Hodgkin lymphoma: Report of the childhood/adolescent/young adult
cancer survivors research program and the BC cancer agency centre
for lymphoid cancer. Br J Haematol. 172:757–768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oeffinger KC and Hudson MM: Long-term
complications following childhood and adolescent cancer:
Foundations for providing risk-based health care for survivors. CA
Cancer J Clin. 54:208–236. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winther JF, Kenborg L, Byrne J, Hjorth L,
Kaatsch P, Kremer LC, Kuehni CE, Auquier P, Michel G, de Vathaire
F, et al: Childhood cancer survivor cohorts in Europe. Acta Oncol.
54:655–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taylor A, Hawkins M, Griffiths A, Davies
H, Douglas C, Jenney M, Wallace WH and Levitt G: Long-term
follow-up of survivors of childhood cancer in the UK. Pediatr Blood
Cancer. 42:161–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Konończuk K, Latoch E,
Żelazowska-Rutkowska B, Krawczuk-Rybak M and Muszyńska-Rosłan K:
Increased levels of adipocyte and epidermal fatty acid-binding
proteins in acute lymphoblastic leukemia survivors. J Clin Med.
10:15672021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Armenian SH, Gibson CJ, Rockne RC and Ness
KK: Premature aging in young cancer survivors. J Natl Cancer Inst.
111:226–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Armstrong GT, Kawashima T, Leisenring W,
Stratton K, Stovall M, Hudson MM, Sklar CA, Robison LL and
Oeffinger KC: Aging and risk of severe, disabling,
life-threatening, and fatal events in the childhood cancer survivor
study. J Clin Oncol. 32:1218–1227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kruseová J, Gottfriedová B, Zichová A,
Švojgr K, Hošek P, Lukš A, Kynčl M and Eckschlager T: Is there a
higher incidence of sporadic renal angiomyolipoma in childhood
cancer survivors? Clin Epidemiol. 13:707–716. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hudson MM, Mertens AC, Yasui Y, Hobbie W,
Chen H, Gurney JG, Yeazel M, Recklitis CJ, Marina N, Robison LR, et
al: Health status of adult long-term survivors of childhood cancer:
A report from the childhood cancer survivor study. JAMA.
290:1583–1592. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van den Berg MH, van Dijk M, Byrne J,
Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL,
Haupt R, et al: Treatment-related fertility impairment in long-term
female childhood, adolescent and young adult cancer survivors:
Investigating dose-effect relationships in a European case-control
study (PanCareLIFE). Hum Reprod. 36:1561–1573. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zichová A, Eckschlager T, Ganevová M,
Malinová B, Lukš A and Kruseová J: Subsequent neoplasms in
childhood cancer survivors. Cancer Epidemiol. 68:1017792020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beekman M, Uh HW, van Heemst D, Wuhrer M,
Ruhaak LR, Gonzalez-Covarrubias V, Hankemeier T,
Houwing-Duistermaat JJ and Slagboom PE: Classification for
longevity potential: The use of novel biomarkers. Front Public
Health. 4:2332016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De la Fuente M: Role of
neuroimmunomodulation in aging. Neuroimmunomodulation. 15:213–223.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang S, Prizment A, Thyagarajan B and
Blaes A: Cancer treatment-induced accelerated aging in cancer
survivors: Biology and assessment. Cancers (Basel). 13:4272021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stelwagen J, Lubberts S, Steggink LC,
Steursma G, Kruyt LM, Donkerbroek JW, van Roon AM, van Gessel AI,
van de Zande SC, Meijer C, et al: Vascular aging in long-term
survivors of testicular cancer more than 20 years after treatment
with cisplatin-based chemotherapy. Br J Cancer. 123:1599–1607.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu J, Wang F, Shi L, Cai H, Zheng Y,
Zheng W, Bao P and Shu XO: Accelerated aging in breast cancer
survivors and its association with mortality and cancer recurrence.
Breast Cancer Res Treat. 180:449–459. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger
SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, et
al: Reduced morbidity and mortality in survivors of childhood acute
lymphoblastic leukemia: A report from the childhood cancer survivor
study. J Clin Oncol. 38:3418–3429. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bøhn SH, Thorsen L, Kiserud CE, Fosså SD,
Lie HC, Loge JH, Wisløff T, Haugnes HS and Reinertsen KV: Chronic
fatigue and associated factors among long-term survivors of cancers
in young adulthood. Acta Oncol. 58:753–762. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spathis A, Hatcher H, Booth S, Gibson F,
Stone P, Abbas L, Barclay M, Brimicombe J, Thiemann P, McCabe MG,
et al: Cancer-related fatigue in adolescents and young adults after
cancer treatment: Persistent and poorly managed. J Adolesc Young
Adult Oncol. 6:489–493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
López-Otín C, Blasco MA, Partridge L,
Serrano M and Kroeme G: The hallmarks of aging. Cell.
153:1194–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayflick L and Moorhead PS: The serial
cultivation of human diploid cell strains. Exp Cell Res.
25:585–621. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blackburn EH and Szostak JW: The molecular
structure of centromeres and telomeres. Annu Rev Biochem.
53:163–194. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kandoth C, McLellan MD, Vandin F, Ye K,
Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al:
Mutational landscape and significance across 12 major cancer types.
Nature. 502:333–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Knudsen ES, Nambiar R, Rosario SR,
Smiraglia DJ, Goodrich DW and Witkiewicz AK: Pan-cancer molecular
analysis of the RB tumor suppressor pathway. Commun Biol.
3:1582020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huan T, Chen G, Liu C, Bhattacharya A,
Rong J, Chen BH, Seshadri S, Tanriverdi K, Freedman JE, Larson MG,
et al: Age-associated microRNA expression in human peripheral blood
is associated with all-cause mortality and age-related traits.
Aging Cell. 17:e126872018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saul D and Kosinsky RL: Epigenetics of
aging and aging-associated diseases. Int J Mol Sci. 22:4012021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vijg J: Somatic mutations, genome
mosaicism, cancer and aging. Curr Opin Genet Dev. 26:141–149. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ness KK, Kirkland JL, Gramatges MM, Wang
Z, Kundu M, McCastlain K, Li-Harms X, Zhang J, Tchkonia T, Pluijm
SMF and Armstrong GT: Premature physiologic aging as a paradigm for
understanding increased risk of adverse health across the lifespan
of survivors of childhood cancer. J Clin Oncol. 36:2206–2215. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kujoth GC, Hiona A, Pugh TD, Someya S,
Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA,
et al: Mitochondrial DNA mutations, oxidative stress, and apoptosis
in mammalian aging. Science. 309:481–484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen H, Vermulst M, Wang YE, Chomyn A,
Prolla TA, McCaffery JM and Chan DC: Mitochondrial fusion is
required for mtDNA stability in skeletal muscle and tolerance of
mtDNA mutations. Cell. 141:280–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kollman C, Howe CW, Anasetti C, Antin JH,
Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R,
et al: Donor characteristics as risk factors in recipients after
transplantation of bone marrow from unrelated donors: The effect of
donor age. Blood. 98:2043–2051. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rossi DJ, Jamieson CHM and Weissman IL:
Stems cells and the pathways to aging and cancer. Cell.
132:681–696. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Flach J, Bakker ST, Mohrin M, Conroy PC,
Pietras EM, Reynaud D, Alvarez S, Diolaiti ME, Ugarte F, Forsberg
EC, et al: Replication stress is a potent driver of functional
decline in ageing haematopoietic stem cells. Nature. 512:198–202.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Janzen V, Forkert R, Fleming HE, Saito Y,
Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE and
Scadden DT: Stem-cell ageing modified by the cyclin-dependent
kinase inhibitor p16INK4a. Nature. 443:421–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jaul E and Barron J: Characterizing the
heterogeneity of aging: A vision for a staging system for aging.
Front Public Health. 9:5135572021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Horvath S: DNA methylation age of human
tissues and cell types. Genome Biol. 14:R1152013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hannum G, Guinney J, Zhao L, Zhang L,
Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al:
Genome-wide methylation profiles reveal quantitative views of human
aging rates. Mol Cell. 49:359–367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Levine ME, Hosgood HD, Chen B, Absher D,
Assimes T and Horvath S: DNA methylation age of blood predicts
future onset of lung cancer in the women's health initiative. Aging
(Albany NY). 7:690–700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu AT, Quach A, Wilson JG, Reiner AP, Aviv
A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, et al: DNA
methylation GrimAge strongly predicts lifespan and healthspan.
Aging (Albany NY). 11:303–327. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Garagnani P, Bacalini MG, Pirazzini C,
Gori D, Giuliani C, Mari D, Di Blasio AM, Gentilini D, Vitale G,
Collino S, et al: Methylation of ELOVL2 gene as a new epigenetic
marker of age. Aging Cell. 11:1132–1134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng Y, Joyce BT, Colicino E, Liu L,
Zhang W, Dai Q, Shrubsole MJ, Kibbe WA, Gao T, Zhang Z, et al:
Blood epigenetic age may predict cancer incidence and mortality.
EBioMedicine. 5:68–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Levine ME, Lu AT, Quach A, Chen BH,
Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y,
et al: An epigenetic biomarker of aging for lifespan and
healthspan. Aging (Albany NY). 10:573–591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kresovich JK, Xu Z, O'Brien KM, Weinberg
CR, Sandler DP and Taylor JA: Methylation-based biological age and
breast cancer risk. J Natl Cancer Inst. 111:1051–1058. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Durso DF, Bacalini MG, Sala C, Pirazzini
C, Marasco E, Bonafé M, do Valle ÍF, Gentilini D, Castellani G,
Faria AMC, et al: Acceleration of leukocytes' epigenetic age as an
early tumor and sex-specific marker of breast and colorectal
cancer. Oncotarget. 8:23237–23245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qin N, Li Z, Song N, Wilson CL, Easton J,
Mulder H, Plyler E, Neale G, Walker E, Zhou X, et al: Epigenetic
age acceleration and chronic health conditions among adult
survivors of childhood cancer. J Natl Cancer Inst. 113:597–605.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Johnson AA, Shokhirev MN, Wyss-Coray T and
Lehallier B: Systematic review and analysis of human proteomics
aging studies unveils a novel proteomic aging clock and identifies
key processes that change with age. Aging Res Rev. 60:1010702020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tanaka T, Biancotto A, Moaddel R, Moore
AZ, Gonzalez-Freire M, Aon MA, Candia J, Zhang P, Cheung F, Fantoni
G, et al: Plasma proteomic signature of age in healthy humans.
Aging Cell. 17:e127992018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Solovev IA, Shaposhnikov MV and Moskalev
A: An overview of the molecular and cellular biomarkers of aging.
Healthy Ageing and Longevity. Springer Nature. (Berlin/Heidelberg,
Germany). 67–78. 2019. View Article : Google Scholar
|
|
52
|
Dimri GP, Lee X, Basile G, Acosta M, Scott
G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O,
et al: A biomarker that identifies senescent human cells in culture
and in aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hurria A, Jones L and Muss HB: Cancer
treatment as an accelerated aging process: Assessment, biomarkers,
and interventions. Am Soc Clin Oncol Educ Book. 35:e516–e522. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shen J, Song R, Fuemmeler BF, McGuire KP,
Chow WH and Zhao H: Biological aging marker p16INK4a in
T cells and breast cancer risk. Cancers (Basel). 12:31222020.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sanoff HK, Deal AM, Krishnamurthy J,
Torrice C, Dillon P, Sorrentino J, Ibrahim JG, Jolly TA, Williams
G, Carey LA, et al: Effect of cytotoxic chemotherapy on markers of
molecular age in patients with breast cancer. J Natl Cancer Inst.
106:dju0572014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Smitherman AB, Wood WA, Mitin N, Ayer
Miller VL, Deal AM, Davis IJ, Blatt J, Gold SH and Muss HB:
Accelerated aging among childhood, adolescent, and young adult
cancer survivors is evidenced by increased expression of
p16INK4a and frailty. Cancer. 126:4975–4983. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wood WA, Krishnamurthy J, Mitin N, Torrice
C, Parker JS, Snavely AC, Shea TC, Serody JS and Sharpless NE:
Chemotherapy and stem cell transplantation increase
p16INK4a expression, a biomarker of T-cell aging.
EBioMedicine. 11:227–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bourlon MT, Velazquez HE, Hinojosa J,
Orozco L, Rios-Corzo R, Lima G, Llorente L, Hernandez-Ramirez DF,
Valentin-Cortez FJ, Medina-Rangel I and Atisha-Fregoso Y:
Immunosenescence profile and expression of the aging biomarker
(p16INK4a) in testicular cancer survivors treated with
chemotherapy. BMC Cancer. 20:8822020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ness KK, Krull KR, Jones KE, Mulrooney DA,
Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar
CA, et al: Physiologic frailty as a sign of accelerated aging among
adult survivors of childhood cancer: A report from the St Jude
Lifetime cohort study. J Clin Oncol. 31:4496–4503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Degesys N, Klein C, Binner M, Browner I
and Shapiro G: Fitness screening in older cancer patients. J Am
Geriatr Soc. 59:S1412011.
|
|
61
|
Collard RM, Boter H, Schoevers RA and Oude
Voshaar RC: Prevalence of frailty in community-dwelling older
persons: A systematic review. J Am Geriatr Soc. 60:1487–1492. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ness KK and Wogksch MD: Frailty and aging
in cancer survivors. Transl Res. 221:65–82. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Williams AM, Krull KR, Howell CR, Banerjee
P, Brinkman TM, Kaste SC, Partin RE, Srivastava D, Yasui Y,
Armstrong GT, et al: Physiologic frailty and neurocognitive decline
among young-adult childhood cancer survivors: A prospective study
from the St Jude lifetime cohort. J Clin Oncol. 39:3485–3495. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hayek S, Gibson TM, Leisenring WM, Guida
JL, Gramatges MM, Lupo PJ, Howell RM, Oeffinger KC, Bhatia S,
Edelstein K, et al: Prevalence and predictors of frailty in
childhood cancer survivors and siblings: A report from the
childhood cancer survivor study. J Clin Oncol. 38:232–247. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Vatanen A, Hou M, Huang T, Söder O,
Jahnukainen T, Kurimo M, Ojala TH, Sarkola T, Turanlahti M,
Saarinen-Pihkala UM and Jahnukainen K: Clinical and biological
markers of premature aging after autologous SCT in childhood
cancer. Bone Marrow Transplant. 52:600–605. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kruseova J, Vicha A, Feriancikova B and
Eckschlager T: Possible mechanisms of subsequent neoplasia
development in childhood cancer survivors: A review. Cancers
(Basel). 13:50642021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wilson CL, Chemaitilly W, Jones KE, Kaste
SC, Srivastava DK, Ojha RP, Yasui Y, Pui CH, Robison LL, Hudson MM
and Ness KK: Modifiable factors associated with aging phenotypes
among adult survivors of childhood acute lymphoblastic leukemia. J
Clin Oncol. 34:2509–2515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bennett JA, Winters-Stone KM, Dobek J and
Nail LM: Frailty in older breast cancer survivors: Age, prevalence,
and associated factors. Oncol Nurs Forum. 40:E126–E134. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Smitherman AB, Anderson C, Lund JL, Bensen
JT, Rosenstein DL and Nichols HB: Frailty and comorbidities among
survivors of adolescent and young adult cancer: A cross-sectional
examination of a hospital-based survivorship cohort. J Adolesc
Young Adult Oncol. 7:374–383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chemaitilly W, Cohen LE, Mostoufi-Moab S,
Patterson BC, Simmons JH, Meacham LR, van Santen HM and Sklar CA:
Endocrine late effects in childhood cancer survivors. J Clin Oncol.
36:2153–2159. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lee SJ and Kim NC: Association between
sarcopenia and metabolic syndrome in cancer survivors. Cancer Nurs.
40:479–487. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lee SJ, Park YJ and Cartmell KB:
Sarcopenia in cancer survivors is associated with increased
cardiovascular disease risk. Support Care Cancer. 26:2313–2321.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Felicetti F, Aimaretti E, Dal Bello F,
Gatti F, Godono A, Saba F, Einaudi G, Collino M, Fagioli F, Aragno
M and Brignardello E: Advanced glycation end products and their
related signaling cascades in adult survivors of childhood Hodgkin
lymphoma: A possible role in the onset of late complications. Free
Radic Biol Med. 178:76–82. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sadowska-Bartosz I and Bartosz G: Effect
of glycation inhibitors on aging and age-related diseases. Mech
Ageing Dev. 160:1–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ariffin H, Azanan MS, Abd Ghafar SS, Oh L,
Lau KH, Thirunavakarasu T, Sedan A, Ibrahim K, Chan A, Chin TF, et
al: Young adult survivors of childhood acute lymphoblastic leukemia
show evidence of chronic inflammation and cellular aging. Cancer.
123:4207–4214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Daniel S, Nylander V, Ingerslev LR, Zhong
L, Fabre O, Clifford B, Johnston K, Cohn RJ, Barres R and Simar D:
T cell epigenetic remodeling and accelerated epigenetic aging are
linked to long-term immune alterations in childhood cancer
survivors. Clin Epigenetics. 10:1382018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Sulicka-Grodzicka J, Surdacki A, Seweryn
M, Mikołajczyk T, Rewiuk K, Guzik T and Grodzicki T: Low-grade
chronic inflammation and immune alterations in childhood and
adolescent cancer survivors: A contribution to accelerated aging?
Cancer Med. 10:1772–1782. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Rossi F, Di Paola A, Pota E, Argenziano M,
Di Pinto D, Marrapodi MM, Di Leva C, Di Martino M and Tortora C:
Biological aspects of inflamm-aging in childhood cancer survivors.
Cancers (Basel). 13:49332021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Smith WA, Li C, Nottage KA, Mulrooney DA,
Armstrong GT, Lanctot JQ, Chemaitilly W, Laver JH, Srivastava DK,
Robison LL, et al: Lifestyle and metabolic syndrome in adult
survivors of childhood cancer: A report from the St. Jude lifetime
cohort study. Cancer. 120:2742–2750. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Clemens E, van der Kooi ALF, Broer L, van
Dulmen-den Broeder E, Visscher H, Kremer L, Tissing W, Loonen J,
Ronckers CM, Pluijm SMF, et al: The influence of genetic variation
on late toxicities in childhood cancer survivors: A review. Crit
Rev Oncol Hematol. 126:154–167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ross JA, Oeffinger KC, Davies SM, Mertens
AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y and
Robison LL: Genetic variation in the leptin receptor gene and
obesity in survivors of childhood acute lymphoblastic leukemia: A
report from the childhood cancer survivor study. J Clin Oncol.
22:3558–3562. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ravera S, Vigliarolo T, Bruno S, Morandi
F, Marimpietri D, Sabatini F, Dagnino M, Petretto A, Bartolucci M,
Muraca M, et al: Identification of biochemical and molecular
markers of early aging in childhood cancer survivors. Cancers
(Basel). 13:52142021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Su HI, Kwan B, Whitcomb BW, Shliakhsitsava
K, Dietz AC, Stark SS, Martinez E, Sluss PM, Sammel MD and
Natarajan L: Modeling variation in the reproductive lifespan of
female adolescent and young adult cancer survivors using AMH. J
Clin Endocrinol Metab. 105:2740–2751. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
George SA, Williamson Lewis R, Schirmer
DA, Effinger KE, Spencer JB, Mertens AC and Meacham LR: Early
detection of ovarian dysfunction by anti-mullerian hormone in
adolescent and young adult-aged survivors of childhood cancer. J
Adolesc Young Adult Oncol. 8:18–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Elchuri SV, Patterson BC, Brown M, Bedient
C, Record E, Wasilewski-Masker K, Mertens AC and Meacham LR: Low
anti-müllerian hormone in pediatric cancer survivors in the early
years after gonadotoxic therapy. J Pediatr Adolesc Gynecol.
29:393–399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
de Vet A, Laven JS, de Jong FH, Themmen AP
and Fauser BC: Antimüllerian hormone serum levels: A putative
marker for ovarian aging. Fertil Steril. 77:357–362. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
van Dorp W, van den Heuvel-Eibrink MM,
Stolk L, Pieters R, Uitterlinden AG, Visser JA and Laven JS:
Genetic variation may modify ovarian reserve in female childhood
cancer survivors. Hum Reprod. 28:1069–1076. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
van der Perk MEM, Broer L, Yasui Y,
Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE,
Versluys B, Bresters D, et al: Effect of genetic variation in
CYP450 on gonadal impairment in a european cohort of female
childhood cancer survivors, based on a candidate gene approach:
Results from the PanCareLIFE study. Cancers (Basel). 13:45982021.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Salas C, Niembro A, Lozano V, Gallardo E,
Molina B, Sánchez S, Ramos S, Carnevale A, Pérez-Vera P, Rivera
Luna R and Frias S: Persistent genomic instability in peripheral
blood lymphocytes from Hodgkin lymphoma survivors. Environ Mol
Mutagen. 53:271–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Smith LM, Evans JW, Mori M and Brown JM:
The frequency of translocations after treatment for Hodgkin's
disease. Int J Radiat Oncol Biol Phys. 24:737–742. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Song N, Li Z, Qin N, Howell CR, Wilson CL,
Easton J, Mulder HL, Edmonson MN, Rusch MC, Zhang J, et al:
Shortened leukocyte telomere length associates with an increased
prevalence of chronic health conditions among survivors of
childhood cancer: A report from the St. Jude lifetime cohort. Clin
Cancer Res. 26:2362–2371. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang J, Van Den Berg D, Hwang AE,
Weisenberger D, Triche T, Nathwani BN, Conti DV, Siegmund K, Mack
TM, Horvath S and Cozen W: DNA methylation patterns of adult
survivors of adolescent/young adult Hodgkin lymphoma compared to
their unaffected monozygotic twin. Leuk Lymphoma. 60:1429–1437.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lipshultz SE, Anderson LM, Miller TL,
Gerschenson M, Stevenson KE, Neuberg DS, Franco VI, LiButti DE,
Silverman LB, Vrooman LM, et al: Impaired mitochondrial function is
abrogated by dexrazoxane in doxorubicin-treated childhood acute
lymphoblastic leukemia survivors. Cancer. 22:946–953. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Krull KR, Hardy KK, Kahalley LS, Schuitema
I and Kesler SR: Neurocognitive outcomes and interventions in
long-term survivors of childhood cancer. J Clin Oncol.
36:2181–2189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Armstrong GT, Reddick WE, Petersen RC,
Santucci A, Zhang N, Srivastava D, Ogg RJ, Hillenbrand CM, Sabin N,
Krasin MJ, et al: Evaluation of memory impairment in aging adult
survivors of childhood acute lymphoblastic leukemia treated with
cranial radiotherapy. J Natl Cancer Inst. 105:899–907. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Krull KR, Sabin ND, Reddick WE, Zhu L,
Armstrong GT, Green DM, Arevalo AR, Krasin MJ, Srivastava DK,
Robison LL and Hudson MM: Neurocognitive function and CNS integrity
in adult survivors of childhood Hodgkin lymphoma. J Clin Oncol.
30:3618–3624. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Guida JL, Ahles TA, Belsky D, Campisi J,
Cohen HJ, DeGregori J, Fuldner R, Ferrucci L, Gallicchio L,
Gavrilov L, et al: Measuring aging and identifying aging phenotypes
in cancer survivors. J Natl Cancer Inst. 111:1245–1254. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Guida JL, Agurs-Collins T, Ahles TA,
Campisi J, Dale W, Demark-Wahnefried W, Dietrich J, Fuldner R,
Gallicchio L, Green PA, et al: Strategies to prevent or remediate
cancer and treatment-related aging. J Natl Cancer Inst.
113:112–122. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
van Kalsbeek RJ, van der Pal HJH, Kremer
LCM, Bardi E, Brown MC, Effeney R, Winther JF, Follin C, den
Hartogh J, Haupt R, et al: European PanCareFollowUp recommendations
for surveillance of late effects of childhood, adolescent, and
young adult cancer. Eur J Cancer. 154:316–328. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Trama A, Bernasconi A, Botta L, Byrne J,
Grabow D, Reulen RC, Calaminus G and Terenziani M: Late mortality
reduction among survivors of germ cell tumors in childhood and
adolescence in Europe: A report from the PanCareSurFup cohort.
Pediatr Blood Cancer. 69:e299912022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Grabow D, Kaiser M, Hjorth L, Byrne J,
Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, et
al: The PanCareSurFup cohort of 83,333 five-year survivors of
childhood cancer: A cohort from 12 European countries. Eur J
Epidemiol. 33:335–349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Braam KI, van der Torre P, Takken T,
Veening MA, van Dulmen-den Broeder E and Kaspers GJ: Physical
exercise training interventions for children and young adults
during and after treatment for childhood cancer. Cochrane Database
Syst Rev. 3:CD0087962016.PubMed/NCBI
|
|
103
|
Wiley CD and Campisi J: The metabolic
roots of senescence: Mechanisms and opportunities for intervention.
Nat Metab. 3:1290–1301. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lee MB, Hill CM, Bitto A and Kaeberlein M:
Antiaging diets: Separating fact from fiction. Science.
374:eabe73652021. View Article : Google Scholar : PubMed/NCBI
|
